ABPI Rare Disease Day commentary – Equity in the age of advanced therapies
On The Pulse Director, Laurence Woollard, MSc, has written a commentary for the Association of the British Pharmaceutical Industry (ABPI) in recognition […]
On The Pulse Director, Laurence Woollard, MSc, has written a commentary for the Association of the British Pharmaceutical Industry (ABPI) in recognition […]
A new Midlands-wide service evaluation is underway to better understand how people living with inherited bleeding disorders access, understand and use treatment-related […]
On The Pulse Director, Laurence Woollard, MSc, features as an expert guest in a special roundtable hosted by EMJ, discussing the current landscape […]
A new editorial, published in the peer-reviewed open access journal Therapeutic Advances in Rare Disease (TAIRD), examines the potential effects of sensationalised […]
The November edition of ‘BioTuesday’, organised by OBN, will focus on rare disease research and development (R&D) in the UK and features […]
A new survey has been launched to better understand how rare disease patient advocacy groups (PAGs) in the UK account for their […]
A Letter to the Editor (LTTE) has been published in the latest issue of the highly-regarded Journal of Thrombosis and Haemostasis (JTH), […]
We are pleased to announce that Laurence Woollard is joining NHS England’s specialised blood disorders Clinical Reference Group (CRG) in a personal […]
It’s been a busy second half of 2022 at On The Pulse HQ. To close out the year, here’s a round-up of […]
We are excited to be participating in-person at the World Federation of Hemophilia (WFH) 2022 World Congress, taking place between Sunday, May […]
